Conditions: Type 2 Diabetes Mellitus Coronary Atherosclerosis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 351
Healthy volunteers: no

Brief summary:
The study aimed to prospectively investigate the prevalence of myocardial scar on Dotarem-enhanced Cardiovascular Magnetic Resonance Imaging (MRI) in asymptomatic patients with type-2 Diabetes Mellitus and to assess its correlation with subclinical coronary artery disease on Cardiac Computed Tomography Angiography (CCTA).

Detailed description:
Patients underwent a cardiac MRI examination with Dotarem within 60 days after screening visit. The myocardial CCTA examination with Xenetix 350 was performed within 1 to 30 days (but no sooner than 24 hours) after the MRI examination.

Arms:
arm 1: None

Interventions: intervention 1: iobitridol intervention 2: gadoterate meglumine
Intervention descriptions: intervention 1: Xenetix 350 was administered at a dose up to 180 ml, according to the patient's body weight measured on the day of administration. intervention 2: Dotarem was administered at a dose of 0.1 mmol/kg body weight (0.2 ml/kg body weight)

Protocol document: